AML, (acute myelogenous leukemia), is an aggressive cancer of the bone marrow and blood. It is the most common type of leukemia. AML is also known by the following names-acute myeloblastic leukemia, acute myeloid leukemia, acute granulocytic leukemia or acute nonlymphocytic leukemia. Blood cells are malformed and useless. The cells can accumulate in parts of the body.
Acute myelogenous leukemia statistics
- Rare in people under 40 years old
- More common in men than in women
- Average age is 65 years old
- 5-year survival rate
o under 65 years old-33%
o over 65 years old-4%
- 2007 it is predicted there will be 13,000 cases (majority will be adults)
The symptoms of acute myelogenous leukemia include abnormal blood counts, a general run-down, unwell feeling that never gets better, reoccurring infections, swollen lymph nodes, and bone/ joint pain. Symptoms are acute (comes on suddenly, and accelerates quickly) instead of chronic (mild symptoms that gradually worsen over years).
When the malformed cells collect around parts of the body, it can cause skin, lung, central nervous system, kidney, and even testicle problems. Initially, acute myelogenous leukemia may mimic other conditions. Blood tests identify the possibility of AML. The final diagnosis is usually made after a bone marrow test and sometimes by a spinal tap, also known as a lumbar (lower spine) puncture (LP).
There are several types treatments available, one or more will be used to treat a dignosis of AML.
Chemotherapy-strong drugs taken orally or intravenously that kills the cancer cells. Occasionally it's injected directly into the spine. It is a systemic treatment because it travels throughout the whole body.
Radiation-high energy rays like X-rays kill the cancer cells
Bone marrow transplants-unhealthy cancer producing bone marrow is destroyed and replaced with matching bone marrow.
Immunotherapy-stimulates the immune system to destroy cancer cells or boosts natural defenses. It can be a made naturally or artificially.
Risk factors for AML
- Previous chemotherapy or radiation treatments
- Exposure to radiation and chemicals like benzene
- Genetic disorders like Downs Syndrome
- Blood disorders like myelodysplasia.
People with risk factors should watch more closely for symptoms of AML because early treatment increases survival rate.
Artice Source: http://www.articlesphere.com
Related Articles in Leukemia Lymphoma Cancer
People interested in the above article are also interested in the related articles listed below:
People suffering from leukemia suffer from one of the deadliest types of blood cancers. It is specifically, a form of cancer of the white blood cells. In modern-day practice, leukemia can also refer to malignancy in the blood or any cellular element in the bone marrow, wherein, the white blood cells multiply uncontrollably. This results to more white blood cells in the bloodstream. This type of blood cancer usually occurs in children with ages between 3 to 7 years while in adults, it occurs between ages 50 to 60 years old.
Non-Hodgkin's lymphoma is a slow-growing, life-threatening cancer of the immune system that develops when white blood cells grow uncontrollably in the lymph nodes. Each year in the U.S. alone, 55,000 new cases are diagnosed. Fortunately, novel, highly personalized treatments are being produced. With a recent medical breakthrough, patients can now receive individualized treatment that kills cancerous cells while sparing normal, healthy cells.
Leukemia is a type of cancer that affects the blood and bone marrow. There are two types of leukemia, chronic and acute, which are treated differently and have different symptoms. Acute leukemia rapidly progresses and needs immediate, aggressive treatment. Chronic leukemia can take months or years to show symptoms and may not need immediate treatment but will require ongoing monitoring.
in Leukemia Lymphoma Cancer